APA (7th ed.) Citation

Bielinska, I. V., Kuznietsova, H. M., Dziubenko, N. V., Savych, Y. V., Milokhov, D. S., Khylia, O. V., & Rybalchenko, T. V. (2021). Application of 1-(4-Cl-benzyl)-3-Cl-4-(CF3 phenylamino)-1H-pyrrole-2,5-dione as a panspecific protein kinase inhibitor for inhibition of hematological complications in experimental chronic cholangitis in rats.

Chicago Style (17th ed.) Citation

Bielinska, I. V., H. M. Kuznietsova, N. V. Dziubenko, Yu. V. Savych, D. S. Milokhov, O. V. Khylia, and T. V. Rybalchenko. Application of 1-(4-Cl-benzyl)-3-Cl-4-(CF3 Phenylamino)-1H-pyrrole-2,5-dione as a Panspecific Protein Kinase Inhibitor for Inhibition of Hematological Complications in Experimental Chronic Cholangitis in Rats. 2021.

MLA (8th ed.) Citation

Bielinska, I. V., et al. Application of 1-(4-Cl-benzyl)-3-Cl-4-(CF3 Phenylamino)-1H-pyrrole-2,5-dione as a Panspecific Protein Kinase Inhibitor for Inhibition of Hematological Complications in Experimental Chronic Cholangitis in Rats. 2021.

Warning: These citations may not always be 100% accurate.